Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness

被引:11
|
作者
Omori, Hirofumi [1 ,2 ]
Sato, Kuniaki [1 ]
Nakano, Takafumi [1 ]
Wakasaki, Takahiro [2 ]
Toh, Satoshi [1 ]
Taguchi, Kenichi [3 ]
Nakagawa, Takashi [2 ]
Masuda, Muneyuki [1 ]
机构
[1] Natl Hosp Org, Kyushu Canc Ctr, Dept Head & Neck Surg, Minami Ku, 3-1-1 Notame, Fukuoka, Fukuoka 8111395, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
[3] Natl Kyushu Canc Ctr, Dept Pathol, Minami Ku, 3-1-1 Notame, Fukuoka, Fukuoka 8111395, Japan
关键词
YAP1; SOX2; KLF7; Cancer stem cell; Head and neck squamous cell carcinoma; SELF-RENEWAL; CANCER; SOX2; YAP; EXPRESSION; INVASION; YAP/TAZ; COACTIVATOR; PROGRESSION; INHIBITION;
D O I
10.1007/s00432-019-02995-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The clinical importance of cancer stem cells (CSCs) in head and neck squamous cell carcinoma (HNSCC) is well recognized. However, a reliable method for the detection of functioning CSC has not yet been established. We hypothesized that YAP1, a transcriptional coactivator, and SOX2, a master transcription factor of SCC, may cooperatively induce stemness through transcriptional reprogramming. Methods We immunohistochemically examined the expression of SOX2 and YAP1 in the CD44 variant 9 (CD44v9)-positive invasion front. A CSC-inducible module was identified through a combination of siRNAs and sphere formation assays. YAP1 and SOX2 interactions were analyzed in vitro. Results The triple overexpression of SOX2, YAP1, and CD44v9 was significantly associated with poor prognosis. TCGA data revealed that the CSC-inducible module, which was related to EMT and angiogenesis, was significantly correlated with poor prognosis. The KLF7 expression, representatively chosen from the module, also correlated with poor prognosis and was essential for sphere formation and CSC propagation. Sphere stress-activated YAP1 enhanced SOX2 activity. Conclusions The stress-triggered activation of YAP1/SOX2 transcriptionally reprograms HNSCC for the acquisition of stemness. Triple SOX2, YAP1, and CD44v9 immunostaining assays may be useful for the selection of high-risk patients with functioning CSCs, and YAP1 targeting may lead to the development of a CSC-targeting therapy.
引用
收藏
页码:2433 / 2444
页数:12
相关论文
共 50 条
  • [1] Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness
    Hirofumi Omori
    Kuniaki Sato
    Takafumi Nakano
    Takahiro Wakasaki
    Satoshi Toh
    Kenichi Taguchi
    Takashi Nakagawa
    Muneyuki Masuda
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2433 - 2444
  • [2] Clinical significance of YAP1 activation in head and neck squamous cell carcinoma
    Eun, Young-Gyu
    Lee, Dongjin
    Lee, Young Chan
    Sohn, Bo Hwa
    Kim, Eui Hyun
    Yim, Sun Young
    Kwon, Kee Hwan
    Lee, Ju-Seog
    ONCOTARGET, 2017, 8 (67) : 111130 - 111143
  • [3] SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma
    Chai, Yuhang
    Li, Qihang
    Zhao, Hongying
    Zhang, Zhiyu
    Yu, Xiaodan
    Pang, Lijuan
    Liu, Zheng
    Zhao, Jin
    Wang, Lianghai
    Li, Feng
    CANCER MEDICINE, 2019, 8 (16): : 7055 - 7064
  • [4] The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma
    Jin Li
    Zhongwu Li
    Yaping Wu
    Yanling Wang
    Dongmiao Wang
    Wei Zhang
    Hua Yuan
    Jinhai Ye
    Xiaomeng Song
    Jianrong Yang
    Hongbing Jiang
    Jie Cheng
    Cell Death & Disease, 10
  • [5] The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma
    Li, Jin
    Li, Zhongwu
    Wu, Yaping
    Wang, Yanling
    Wang, Dongmiao
    Zhang, Wei
    Yuan, Hua
    Ye, Jinhai
    Song, Xiaomeng
    Yang, Jianrong
    Jiang, Hongbing
    Cheng, Jie
    CELL DEATH & DISEASE, 2019, 10 (8)
  • [6] SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma
    Chung, Ji Hyun
    Jung, Hae Rim
    Jung, Ah Ra
    Lee, Young Chan
    Kong, Moonkyoo
    Lee, Ju-Seog
    Eun, Young-Gyu
    SCIENTIFIC REPORTS, 2018, 8
  • [7] SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma
    Ji Hyun Chung
    Hae Rim Jung
    Ah Ra Jung
    Young Chan Lee
    Moonkyoo Kong
    Ju-Seog Lee
    Young-Gyu Eun
    Scientific Reports, 8
  • [8] Correction: The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma
    Jin Li
    Zhongwu Li
    Yaping Wu
    Yanling Wang
    Dongmiao Wang
    Wei Zhang
    Hua Yuan
    Jinhai Ye
    Xiaomeng Song
    Jianrong Yang
    Hongbing Jiang
    Jie Cheng
    Cell Death & Disease, 15 (12)
  • [9] SOX2 as a Potential Therapeutic Target in Squamous Cell Carcinoma of the Head and Neck
    Bode, M.
    Schrock, A.
    Bareiss, P. M.
    Goke, F.
    Franzen, A.
    Kirsten, R.
    von Massenhausen, A.
    van Bremen, T.
    Bootz, F.
    Kristiansen, G.
    Lengerke, C.
    Perner, S.
    MODERN PATHOLOGY, 2013, 26 : 304A - 304A
  • [10] SOX2 as a Potential Therapeutic Target in Squamous Cell Carcinoma of the Head and Neck
    Bode, M.
    Schrock, A.
    Bareiss, P. M.
    Goke, F.
    Franzen, A.
    Kirsten, R.
    von Massenhausen, A.
    van Bremen, T.
    Bootz, F.
    Kristiansen, G.
    Lengerke, C.
    Perner, S.
    LABORATORY INVESTIGATION, 2013, 93 : 304A - 304A